Skip to main content

Together we are beating cancer

Donate now

Children and young people's cancers

Children develop different types of cancers than adults, with around 1,900 children under the age of 14 diagnosed each year. The most common types of childhood cancer are acute leukaemia and cancers of the brain and spinal cord. Thanks to research into new treatments, 8 in 10 children diagnosed with cancer will live for at least five years.
Showing 12 out of 208 results
Two cancer researchers looking at a cell image on screen

For Childhood Cancer Awareness Month, we're highlighting some our most important research into children's and young peoples' cancers over the past year. For Childhood Cancer Awareness Month, we're highlighting some our most important research into children's and young peoples' cancers over the past year.

by Momoko Bowles | Analysis | 1 September 2024

1 September 2024

Brain scans

Stand Up To Cancer are giving two international teams each a further £3.75m to reduce the side effects of radiotherapy and make immunotherapies work for more young patients. Stand Up To Cancer are giving two international teams each a further £3.75m to reduce the side effects of radiotherapy and make immunotherapies work for more young patients.

by Tim Gunn | Analysis | 7 August 2024

7 August 2024

Cancer Research UK scientists in the lab

NHS England will offer the newly-approved dabrafenib plus trametinib combination to children and young people whose gliomas are being driven by a specific genetic mutation. NHS England will offer the newly-approved dabrafenib plus trametinib combination to children and young people whose gliomas are being driven by a specific genetic mutation.

by Tim Gunn | News | 13 June 2024

13 June 2024

Issy, Jake and Joram, who shared their stories with us for Teenage and Young Adult Cancer Awareness Month.

April is Teenage and Young Adult Cancer Awareness Month. Three teenagers who were diagnosed with cancer share their experiences and advice. April is Teenage and Young Adult Cancer Awareness Month. Three teenagers who were diagnosed with cancer share their experiences and advice.

by Tom Bourton, Tim Gunn | Personal stories | 2 April 2024

2 April 2024

A Cancer Research UK-funded researcher in the lab.

We helped fund a trial into neuroblastoma treatment that has improved how doctors treat the disease when other options aren't working. It's an important step forward in treating these relapsed and refractory tumours, which have some of the lowest survival rates for any childhood cancer.   We helped fund a trial into neuroblastoma treatment that has improved how doctors treat the disease when other options aren't working. It's an important step forward in treating these relapsed and refractory tumours, which have some of the lowest survival rates for any childhood cancer.  

by Tim Gunn | News | 10 January 2024

10 January 2024

Bacterial microbiome mapping. Orange lines making connections and overlapping each other.

The microbiome is made up of trillions of microbes, including bacteria, fungi and even viruses. A research group believes this bustling community could be the key for preventing childhood acute lymphoblastic leukaemia. The microbiome is made up of trillions of microbes, including bacteria, fungi and even viruses. A research group believes this bustling community could be the key for preventing childhood acute lymphoblastic leukaemia.

by Sophie Wedekind | Analysis | 3 January 2024

3 January 2024

Cancer Research UK and Children with Cancer UK will co-fund a £5.5 million research programme to advance precision medicine for children and young people whose cancer has returned or whose treatment has stopped working. Cancer Research UK and Children with Cancer UK will co-fund a £5.5 million research programme to advance precision medicine for children and young people whose cancer has returned or whose treatment has stopped working.

by Sophie Wedekind | News | 20 November 2023

20 November 2023

This entry is part 11 of 25 in the series That Cancer Conversation
Steph Phillips, Dr Miriam Dixon-Zegeye & Professor Sarah Blagden

We're funding the UK's first precision cancer prevention trial unit. It's testing a drug that could help protect people with Li Fraumeni Syndrome, a genetic condition that can lead to a more than 90% lifetime risk of cancer, against the disease. We're funding the UK's first precision cancer prevention trial unit. It's testing a drug that could help protect people with Li Fraumeni Syndrome, a genetic condition that can lead to a more than 90% lifetime risk of cancer, against the disease.

by Tim Gunn | In depth | 19 September 2023

19 September 2023